Skip to content
← Back to this collection

PUBLICATIONS · 17162009

Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Urol
Publication date
2007 Jan
First author
Lin CC

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Lin CC
      type
      Author
    2. name
      Hsu CH
      type
      Author
    3. name
      Huang CY
      type
      Author
    4. name
      Cheng AL
      type
      Author
    5. name
      Vogelzang NJ
      type
      Author
    6. name
      Pu YS
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Lin CC
      type
      Author
    2. name
      Hsu CH
      type
      Author
    3. name
      Huang CY
      type
      Author
    4. name
      Cheng AL
      type
      Author
    5. name
      Vogelzang NJ
      type
      Author
    6. name
      Pu YS
      type
      Author
    bibliography ids
    1. nci-bib-9f08def036f77eb7be3684c4
    book metadata
    content sha256
    3a8abfba37b466208a9495192a5ca7c07325cd40dcf648c14a94702b860760e7
    document type
    citation
    dois
    1. 10.1016/j.juro.2006.08.058
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:17162009
    immutable id
    pubmed:17162009@3a8abfba37b466208a9495192a5ca7c07325cd40dcf648c14a94702b860760e7
    journal
    abbreviation
    J Urol
    issn electronic
    Source null
    issn print
    0022-5347
    issue
    1
    name
    The Journal of urology
    nlm unique id
    0376374
    pages
    84-9; discussion 89
    volume
    177
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      17162009
      provenance
      batch id
      e687ecc838c318f9ec65
      provider
      NCBI PubMed ESummary
      record sha256
      becd1b8d312bcb14a456275074c877db663f9b1309d852e75860cb7a36a768e9
      response sha256
      57c28819ed5384f58bd55b57a106357c87d58ddac21f26fe526ca7520d9f61c6
      retrieved at
      2026-09-09T23:46:11.674833+00:00
      publication date
      display
      2007 Jan
      precision
      month
      year
      2007
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/17162009/
      title
      Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.

      Preserved source evidence · Not medical advice